Platelets: A possible glance into brain biological processes in schizophrenia

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Schizophrenia is a severe mental disorder with unclear biological underpinnings, necessitating objective biomarkers.
• Current diagnostic and prognostic methods rely on subjective assessments, highlighting the need for biological markers.
• Platelets serve as a valuable model for neurobiological research due to their accessibility and neuronal similarities.

Purpose of the Study:

• To review platelet physiology changes in schizophrenia.
• To examine platelet responses to antipsychotic medication.
• To explore the potential of platelets as biomarkers for schizophrenia.

Main Methods:

• Review of numerous studies on platelet physiology in schizophrenia.
• Analysis of research on neurotransmitter metabolism, phospholipid abnormalities, and mitochondrial function in platelets.
• Examination of platelet changes in relation to antipsychotic treatment.

Main Results:

• Schizophrenia is associated with impaired platelet neurotransmitter metabolism, altered phospholipid and fatty acid profiles, and mitochondrial dysfunction.
• These platelet abnormalities align with various etiological hypotheses of schizophrenia.
• Despite extensive research, no single, reliable platelet biomarker for schizophrenia has been identified.

Conclusions:

• Platelet research offers insights into schizophrenia's pathophysiology but has not yielded a definitive biomarker.
• The clinical heterogeneity and biological complexity of schizophrenia suggest biomarkers may be subgroup-specific or consist of multiple interrelated factors.
• Further research is needed to identify reliable biomarkers, potentially through analyzing arrays of factors within defined patient subgroups.